MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5455/medarh.2022.76.72-74

Медицинская библиотека · Medical archives (Sarajevo, Bosnia and Herzegovina) · 2022

Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine.

Alzoabi Nasser, Alqahtani Jamal, Algamdi Bader, Almutairi Mohammed, Alratroot Jumana, Alkhaldi Saud, Alqahtani Shatha, Alakloby Omar

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND

Erythema nodosum (EN) is a common form of panniculitis that could be triggered by numerous conditions including infectious and non-infectious conditions. So far, few cases of EN caused by COVID-19 vaccine had been reported.

CASE REPORT: We report a case of atypical presentation of EN mimicking cellulitis in a patient who received the first dose of the Pfizer-BioNTech COVID-19 vaccine. A 38-year-old healthy woman who developed painful swelling on the left leg one week after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine. Skin biopsy was revealed septal panniculitis. Due to the temporal association and the absence of other identifiable causes, Pfizer-BioNTech COVID-19 vaccine-related EN would be the most likely explanation.

CONCLUSION

COVID-19 vaccines could be associated with rare side effects that should be reported for a better understanding of related outcomes of COVID-19 vaccination. This case was reported to keep in mind that EN can have atypical presentation as a rare side effect of COVID-19 vaccines.

Для цитирования: Alzoabi Nasser, Alqahtani Jamal, Algamdi Bader, Almutairi Mohammed, Alratroot Jumana, Alkhaldi Saud, Alqahtani Shatha, Alakloby Omar. Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine.. Medical archives (Sarajevo, Bosnia and Herzegovina). 2022. DOI: 10.5455/medarh.2022.76.72-74.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.